Medical University of South Carolina

MEDICA
MUSC Theses and Dissertations
2015

Extensive and Persistent Disruption of Neurovascular Coupling by
a Single Cerebral Microinfarct
Philipp McConnell Summers
Medical University of South Carolina

Follow this and additional works at: https://medica-musc.researchcommons.org/theses

Recommended Citation
Summers, Philipp McConnell, "Extensive and Persistent Disruption of Neurovascular Coupling by a Single
Cerebral Microinfarct" (2015). MUSC Theses and Dissertations. 484.
https://medica-musc.researchcommons.org/theses/484

This Thesis is brought to you for free and open access by MEDICA. It has been accepted for inclusion in MUSC
Theses and Dissertations by an authorized administrator of MEDICA. For more information, please contact
medica@musc.edu.

ii
PHILIPP MCCONNELL SUMMERS. Extensive and Persistent Disruption of
Neurovascular Coupling by a Single Cerebral Microinfarct. (Under the direction of Andy
Shih).

Abstract
Cerebral microinfarcts (CMI), microscopic brain lesions caused by blockade of small
blood vessels, have recently emerged as a potential determinant of cognitive
decline. Though small in size, our recent work demonstrated that a single,
strategically placed CMI was sufficient to disrupt sensory input in a behavioral task.
However, the means by which such small lesions disrupt brain function remain
poorly understood. We imaged vascular function in awake, head-fixed mice using
two-photon microscopy to examine the impact of CMI on neurovascular coupling.
CMI were generated in cortex by photothrombotic occlusion of single penetrating
vessels through a thinned-skull cranial window. Vibrissa-evoked dilation of individual
arteries and arterioles within the primary vibrissa cortex were tracked over four time
periods: pre-occlusion, acute (2-3 days post-occlusion), subacute (7-9 days) and
chronic (14-21 days). In the acute phase, dilatory responses were markedly
attenuated compared to pre-occlusion (2.2 ± 0.5% mean dilation over baseline vs.
11.2 ± 0.8%, p < 0.001). Dilatory responses during the subacute (7.8 ± 1.1%) and
chronic (6.5 ± 1.1%) phases partially recovered but remained significantly attenuated
in magnitude and time to dilation compared to pre-occlusion (p < 0.01). Critically,
vascular dysfunction was observed well beyond the borders of the CMI, as infarcts
with an average radius of 0.19 ± 0.05 mm generated deficits in dilation at distances
exceeding 1 mm away from the vessel targeted for occlusion. Analysis of dilations in
a separate cohort of mice during the hyperacute time period (0-3 hours postocclusion), revealed that the dilatory deficit is first expressed in the immediate
vicinity of the stroke and then propagates outward from the occlusion site. While
unresponsive to sensory stimulation, vasodilation could be evoked by isoflurane
inhalation, albeit attenuated in the subacute phase (156.7 ± 5.3% of pre-stroke levels
vs. 134.6 ± 4.3% subacute, p = 0.02). Expression of c-Fos following an extended
period of vibrissa stimulation was reduced in the peri-infarct tissue in the acute time
period, with gradual recovery initiating distal to the stroke apparent in subacute and
chronic mice. This indicated that loss of sensory-evoked vasodilation is attributed to
a combination of altered vascular mechanical properties and a deficit in neural
connectivity and/or activity. Thus, CMI disrupt brain function well beyond the regions
of overt tissue infarction and this effect, combined with their widespread distribution
in the aged brain, may contribute to the pathogenesis of CMI in vascular dementia.
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Introduction
Vasculature of the Brain
The constant energy demands of brain function must be supplied by a
reliable and dynamic cerebrovascular system (1). The cerebral cortex is supplied
by the great cerebral arteries that emanate from the Circle of Willis and source a
planar network of highly interconnected pial arterioles on the brain surface (2).
Blood flow in this network is relatively insensitive to blockages (3, 4), and also
permits the dynamic redistribution of blood toward regions of heightened
electrical activity (5,6).

Figure 1. Vasculature of the mouse cortex.
(A) Vasculature of the dorsal surface of the of the whole mouse brain revealed by a fluoresceingelatin cast. (B) Schematic of the three-tiered topology of vasculature in the mouse cortex,
containing highly interconnected surface pial networks, penetrating vessels which create
bottlenecks in flow, and subsurface microvascular networks. Adapted from Blinder et al. (7).(C)
Illustration of penetrating vessels projecting radially from the pial surface into deep layers of the
cortex Adapted from Shih et al. (8).

These pial vessels are in turn connected to an underlying, threedimensional network of microvessels by penetrating arterioles that project radially
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from the surface, as shown in Figure 1B, forming bottlenecks in flow to columns
of cortical microvasculature (7). Blood is drained from the microvasculature back
to the cortical surface through penetrating venules and then emptied into the
central sinus.
The physiological demands served by the blood supply of the brain are
particularly significant because neurons are more sensitive to oxygen deprivation
than other kinds of cells with lower rates of metabolism (9). The brain is also at
risk from circulating toxins, and is specifically protected in this respect by
the blood-brain barrier.

In addition to having a high metabolic rate, neurons

obtain virtually all of their nutrition via aerobic metabolism of glucose, making
them even more reliant on persistent oxygenation (10). When blood supply is
compromised, deprivation of oxygen and glucose may cause transient or
permanent damage to brain tissue. Even a brief loss of blood supply can initiate
cellular changes which lead to cell death, while a prolonged loss of blood flow
leads more directly to death and degeneration of affected cells (9).

Neurovascular Coupling

Cerebral metabolism depends on a constant supply of both glucose and
oxygen. A continuous supply of these two energy substrates is maintained by
cerebral blood flow (CBF), which delivers glucose and oxygen to neural tissue
through the complex web of blood vessels in the brain’s vascular system.
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Accordingly, during neural activity, increases in oxygen and glucose consumption
are followed by an increase in CBF (11). While the increase in CBF is
comparable to the rise in glucose consumption rate, the rate of oxygen
consumption is fractionally smaller in magnitude, resulting in an increase in the
relative concentration of oxygen in blood and tissue (12). This oversupply of
oxygen due to the mismatch between CBF and oxygen consumption is the basis
of blood-oxygenation level dependent (BOLD) fMRI, which detects alterations in
levels of deoxygenated hemoglobin and cerebral blood volume (13, 14).

The Neurovascular Unit

Neurovascular coupling is accomplished through the activity of a group of
cells, closely related to each other, called the neurovascular unit (NVU). The
NVU is composed of neurons, astrocytes, endothelial cells of the blood-brain
barrier (BBB), myocytes, and pericytes (15). These components exhibit a tightly
linked anatomical and chemical relationship that detects neuronal metabolic
needs and triggers the necessary vasodilatory or vasoconstrictive response
needed to regulate nutrient distribution and meet such demands. The NVU has
also been implicated in eliciting selective changes in BBB permeability, either
through direct signaling from neurons or alternative pathways through pericytes
and astrocytes which ensheathe the microvasculature (15, 16).
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2-Photon Imaging as a Tool to Study Neurovascular Coupling

Two-photon laser-scanning microscopy (TPLSM) is an imaging technique
which combines the point-by-point rastering technique of confocal laser scanning
microscopy with physical phenomena of two-photon absorption, which is the
simultaneous absorption of two photons to excite a molecule from one state to a
higher energy electronic state (17). As a result of this phenomenon, the two
excitation photons can provide the excitation of a photon with twice their own
energy. Many fluorescent markers used in in-vivo imaging require excitation light
in the visible spectrum, which is scattered at relatively shallow depths in brain
tissue. Two-photon microscopy allows researchers to circumvent these issues
by providing excitation for the same fluorophores from the infra-red spectrum by
way of two-photon absorption, permitting greater depth of imaging with less
scattering of excitation light (18).
The depth of imaging allowed by two-photon microscopy, combined with
the high spatial-acuity of laser scanning microscopy, make this imaging method
one of the most amenable for imaging living tissue up to a very high depth. Due
to multiphoton absorption, the background signal is strongly suppressed,
resulting in improved light detection efficiency, and reduced phototoxicity
compared to confocal microcopy.

In vivo TPLSM is already an established

method to visualize cerebrovascular topology and quantify blood flow at the level
of single vessels in the rodent cortex, and is an excellent tool for probing
neurovascular coupling at the microvascular level in the behaving animal (8).
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Stroke
A stroke is defined as the loss of brain function due to a disturbance in the
blood supply to the brain (19). This can arise either from ischemia, a lack of
blood flow due to a clot or general hypoxia, or hemorrhage, a loss of blood flow
due to rupture of a vessel. The majority of strokes (87%) are ischemic strokes.
Every year, about 800,000 people in the United States have a stroke (20). While
stroke is the fourth leading cause of death in America, killing nearly 130,000
individuals each year (21), a large proportion of patients survive its devastating
effects and require rehabilitation and long-term care to overcome disabilities. As
a result, stroke is a great burden to the economy, costing the United States an
estimated $36.5 billion annually (22).

The Ischemic Cascade

The progression of stroke injury is very complex, involving various
mechanisms of cell death including excitotoxicity, apoptosis, necrosis and
inflammation.

Following the loss of blood supply, stroke begins with the

disruption of metabolism and homeostasis in neurons and glia due to an inability
to generate adequate levels of adenosine triphosphate (ATP) (23). The loss of
ATP-dependent ion channel activity results in a breakdown of ionic gradients
across the plasma membrane, resulting in widespread depolarization of neurons
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and glia and subsequent uncontrolled release of synaptic glutamate (24, 25).
The loss of membrane potential also shuts down Na+-dependent glutamate
transporters,

preventing

reuptake

and

further

exacerbating

extracellular

glutamate accumulation (26).
The rise in glutamate initiates a toxic secondary cascade known as
excitotoxicity (27, 28). The elevated levels of glutamate over-stimulate NMDA
and AMPA-type neuronal glutamate receptors, leading to an influx and
accumulation of Ca++ in the cytosol (29). Intracellular Ca++ overload leads to
mitochondrial dysfunction, compounding the issue of ATP depletion and
triggering the apoptotic cascade.
Cortical spreading depression (CSD) is an intense depolarization wave
that slowly propagates through gray matter. CSD is characterized by a wave of
hyperactivity followed by a wave of depression (30), and is associated with
massive transmembrane ionic and water shifts coupled to a surge in extracellular
K+ (31).

CSD has been found to coincide with tissue hypoxia (32), and

incidences of spreading depression, sometimes termed “injury depolarizations”,
have been detected in the human brain following ischemic stroke, subarachnoid
hemorrhage, intracerebral hemorrhage, and traumatic brain injury (33).

In

ischemic stroke, spreading depressions seem to originate at the junction
between the ischemic core and the moderately ischemic penumbra, where
synaptic activity has ceased, but some neuronal membrane potentials are
preserved. These depolarizations propagate along the infarct rim and often into
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non-ischemic tissue, exerting metabolic and hemodynamic effects that can
worsen the long-term outcome of ischemic tissue (34).
In ischemic stroke, the reduction of CBF is most pronounced in the
ischemic core, while it is less pronounced in the periphery (35). Following focal
and global ischemia, when perfusion is reestablished in the peri-infarct, there is a
transient increase in flow followed by a period of reduced flow. After ischemia,
cerebral circulation experiences some degree of vasoparalysis (36). It has long
been known that, following ischemic stroke, the reactivity of cerebral circulation
to administration of carbon dioxide and vascular autoregulation is altered and
impaired in patients (37). Studies that assess indices of neural activity in patients
suggest that the reduction in neurovascular coupling may be secondary to a
reduction in the neural activity driving the hemodynamic response (38). It has
also been found that the increase in glucose utilization typically evoked by
vibrissa stimulation of rats is severely depressed one day following transient
global ischemia (39), indicating that, in addition to a depressed CBF response,
metabolic responses are attenuated following stroke. Small cortical strokes have
been found to produce a broad region of hypometabolism, termed diaschisis,
outside of the putative ischemic core (40). It is postulated that this is due to
vascular steal (41), or the loss of the CBF to neighboring hypometabolic regions,
and a deficit in neural activity resulting from the loss of afferents that previously
emerged from the stroke core (42).
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CSD may, to some extent, drive these effects, as it has been found to
elicit a strong vasoconstrictive response in the peri-infarct tissue (43).
Widespread vascular oxidative stress could also contribute to loss of
neurovascular coupling.

Ischemia leads to an increase of reactive oxygen

species (ROS), which can cause profound alterations in cerebrovascular
regulation (44), while ROS scavengers ameliorate disturbances in CBF following
ischemia-reperfusion (45).

Effects of Anesthetics on Stroke

Anesthesia alters key mechanisms of stroke injury and repair, and will
therefore affect the trajectory of the disease. In the acute stage of ischemic
injury, this can occur by suppression of neuronal activity or by engaging collateral
blood flow sources. Common anesthetics, such as isoflurane, reduce the
cerebral metabolic rate for oxygen consumption and likely the extent of
excitotoxic neuronal toxicity (46). Ketamine, in particular, is an antagonist of the
NMDA receptor and attenuates production of the potent vasomediator, nitric
oxide, during stroke (47). The frequency of CSD events has been shown to be
attenuated or modulated by numerous anesthetics, including ketamine (48, 49),
volatile anesthetics halothane, isoflurane and sevoflurane (50, 51), and urethanechloralose (52). Thus, many anesthetics mediate an overall protective effect in
stroke by attenuating excitotoxic injury (53).
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Anesthesia can also affect CBF, which may have opposing effects on
stroke outcome. Pentobarbital and isoflurane, in particular, cause global cerebral
vasodilation and a significant reduction in CBF that lead to a hypoperfusion (54).
In the setting of a stroke, this could conceivably decrease perfusion in the stroke
penumbra, exacerbating injury. Conversely, the dilation of cerebral arterioles can
conceivably promote tissue survival by engaging collateral blood supply to the
hypoxic tissue. Another important consideration is that hemodynamic responses
measured by BOLD fMRI are widely used to infer tissue recovery after stroke
(55). Given the suppressive effects of anesthetics on arterial and neuronal
reactivity, it is unclear when models using anesthesia fail to mimic the human
condition (56, 57).
The effects of anesthetics can extend beyond the acute phase of stroke
when the infarct stabilizes and the peri-infarct zone begins to recover.
Longitudinal in vivo imaging studies typically involve repeated periods of
anesthesia that could affect repair/recovery processes. Anesthetics impact the
activity of microglia directly by altering the expression of inflammatory mediators
and also indirectly by reducing CSD, which promotes microglial activation (58).
The effect varies with the type of anesthetic used, as isoflurane appears to
promote cytokine expression (59, 60), while ketamine has an inhibitory effect
(61).

Further, the activity of microglia is tightly linked to post-stroke repair

process through release of matrix metalloproteinases, which are associated with
the breakdown of tight junction proteins in acute stroke (62), but also appear to
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be involved in remodeling of neuronal connectivity (63) and possibly nascent
blood vessel formation (64).
One limitation in current preclinical stroke studies is that the models are
often invasive, necessitating deep and prolonged anesthesia. This precludes the
visualization of early changes in stroke, and can dictate the extent and long-term
trajectory of the injury. To minimize the confounding influence of anesthetics in
this study, mice were imaged and vessels were occluded in the awakened state,
with minimal isoflurane exposure introduced briefly to allow for necessary
injections.

Cerebral Microinfarcts

Cerebral microinfarcts (CMIs) are tiny lesions characterized by genuine
tissue infarction, but on a scale that renders them unapparent in gross pathologic
examination or conventional structural MRI, although there is evidence that in
vivo detection of microinfarcts might soon be possible (65).

Though many

studies have shown that asymptomatic microinfarcts and cerebrovascular
disease are very common, especially with aging, these “silent” strokes are nearly
twice as prevalent in cases of dementia as in the healthy, aged brain (66, 67).
While the clinical relevance of CMIs has been controversial, there is a growing
body of evidence that they impart a deleterious effect on cognitive performance.
In a study where CMIs were introduced in the rat barrel cortex, it was found that
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a single microscopic lesion, similar in size, location and geometry to a human
microinfarct, could produce tissue damage and perceptual deficits which could be
mitigated with administration of memantine, a glutamate receptor antagonist (68).

Targeted Photothrombotic Occlusion

Targeted photothrombotic occlusion is a method by which ischemic
damage is induced within a targeted cortical area by means of photo-activation of
a previously injected light-sensitive dye.

The dye Rose Bengal (4,5,6,7-

tetrachloro-2',4',5',7'-tetraiodofluorescein) is one such photo-sensitizing agent.
When Rose Bengal dye is illuminated with a 530nm laser, singlet oxygen is
produced.

In the intravascular environment, these free radicals damage

components of endothelial cell membranes, leading to platelet aggregation and
thrombi formation, eventually interrupting local blood flow (69). While diffuse light
exposure has been used to generate large, non-specific strokes, emerging
methods have been introduced to produce much smaller strokes, which mimic
the nature of a CMI (70, 71). Using dichroic mirrors, a focused green laser may
be introduced into the same optical pathways as the imaging laser used in a
TPLSM system, allowing for photothrombosis to be targeted specifically to the
lumen of an individual penetrating vessel (72). Following occlusion, the injury
can be left to evolve into a lesion mimicking CMI.
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Methods
Subjects
For this study, male mice from the C57BL/6 line were selected for use.
Mice selected for the study were between 3 to 7 months of age at the time of the
initial surgery, with an average age of 4.7 ± 1.2 months. The mean weight of the
mice selected for the study was 27.2 ± 2.7 grams.

Study Design
Prior to the study, the timeline in Figure 2 was developed to schedule
surgery, habituation, and imaging.

On day one, mice were implanted with a

head-fixation flange imbedded in a skull cap. However, at this time a chronic
window was not created in the skull to mitigate the deterioration of imaging
quality later in the experiment.

Figure 2. Timeline of experimental procedures

The initial surgical procedure was followed by four days of habituation to
head fixation to prepare the mice for awake imaging sessions. On day four of
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habituation, a PoRTS window was created over the left hemisphere of the
mouse. The following day, pre-occlusion imaging was initialized, after which a
single CMI was induced using photothrombosis in the barrel cortex.

Post-

occlusion imaging was then carried out in three time phases: acute (2-3 days
post-occlusion), subacute (7-9 days), and chronic (14-17 days). Following the
completion of chronic imaging, mice were sacrificed and perfused, and the tissue
was labeled using immunohistochemistry techniques.

Surgical Procedure – Head Mount Implantation
Prior to the initiation of habituation, surgical procedures were performed to
create a skull cap and implant a head-mount flange. Mice were first anesthetized
with 4% isoflurane in air in an enclosed container.

Once mice were in an

anesthetized state as determined by the toe-pinch test, they were transferred to
an apparatus under the surgical microscope with 1-2% isoflurane in air provided
through a nose cone. At this time, mice were given a 50µl dose of .03mg/ml
analgesic Buprenex (buprenorphine). The scalp of the mouse was sterilized with
betadine followed by 30% ethanol. The toe-pinch test was performed again to
ensure adequate depth of anesthesia before making any incision. Forceps were
used to pinch and lift the scalp, which was removed with a single, clean incision
using scissors. If any bleeding occurred at this point, sterilized kimwipes were
employed to stop the flow of blood and to clean up the surgical site.
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Sharp forceps were then used to remove the peri-osteum from the surface
of the skull, exposing the bone. The skull surface was scored over the right
hemisphere using the sharp forceps to allow for stronger binding with glue and
dental cement. Additionally, the surface of the skull over the stereotaxic location
of the vibrissa sensory cortex (3.5-4.0mm lateral from the midline and 1.2-2.0
mm caudal to bregma) was marked with a sterilized pencil. A wooden applicator
was used to brush a thin layer of cyanoacrylate glue over the junction of the
exposed skull and the edge of the incision, as well as over the top of pronounced
sutures in the skull. This step is necessary to lock fluids away from the surface
of the skull, which is critical when later creating the PoRTS window.
After allowing the cyanoacrylate glue to dry for 15 minutes, a custom
titanium head mount flange was positioned over the right hemisphere of the skull,
above the scored hash marks. Parkell C&B Metabond self-curing dental cement
was applied to the exposed skull, with larger amounts about the head mount
flange to anchor it to the skull. A thin layer was brushed over the demarcated
vibrissa cortex, allowing the region to still be visually identifiable while protecting
the skull from open exposure. The mice were then removed from the surgical
apparatus and placed in their home cage under a heat lamp for recovery.

Habituation to Head Fixation
Following recovery from the initial surgery, the mice were gradually
introduced to the long-term head fixation necessary for awake imaging in this
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study. On each day, mice were placed into the imaging apparatus as detailed in
Figure 2.

Following brief isoflurane exposure, the mice were fixed to an

anchored arm using the head mount flange and an adjustable cardboard tube
was positioned snugly around the bodies of the mice to minimize movement.
Mice that would later wear the pulse oximeter during imaging were conditioned
with the MouseOx fixed to the left leg as well. On day one, habituation was
carried out for 15 minutes, followed by 30 minutes on day two, 1 hour on day
three, and 2 hours on day four. At the end of day four of habituation, mice that
exhibited characteristics indicative of proper habituation were selected for PoRTS
window surgery.

Surgical Procedure – PoRTS Window Surgery
Prior to the second surgical procedure, mice were anesthetized using the
same techniques utilized before creating the skull cap and implanting the headmount flange. Once mice were determined to be properly anesthetized using the
tail pinch test, they were secured to the surgical apparatus using the head-mount
flange. A dental drill was used at 10,000 rpm to delicately remove the dental
cement over the demarcated vibrissa cortex. After removing the dental cement,
exposing the underlying bone, the drill tip was replaced, as wear and tear
resulting from drilling through the cement could be deleterious when drilling
through bone. The skull was gradually thinned, periodically clearing debris using
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an air canister and applying cool ACSF to the skull surface to dissipate heat
created through the friction of drilling.

The skull was determined to be

adequately thinned when microvasculature became clearly visible with no
aberrations following the application of ACSF, indicating a width of about 10-20
µm. The skull was then dried using kimwipes and the air canister. As shown in
Figure 3, a thin layer of cyanoacrylate glue was applied to the thinned skull and
a No. 0 coverslip was placed over the glue, resulting in a clear optical interface.

Figure 3. Schematic of PoRTS window for imaging mouse cortex.
Schematic showing the cross section of a PoRTS window. A thin layer of glue was applied to the
thinned skull and a cover glass was place above (73).

Imaging Setup
Imaging was performed using a custom Sutter two-photon microscopy
setup powered by a tunable Coherent Ti-Sapphire laser. The freeware package
MPScope 2.0 was used to control the laser scanning system (74, 75). Images
and movies collected using this program were stored as .MPD files, a custom file
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type, which allows for images across multiple channels to be packaged with cosynchronous signals if desired.
Mice were fixed into an imaging apparatus using the head mount flange
and were additionally restrained with an adjustable cardboard tube. As shown
below in Figure 4, an ADXL accelerometer was fixed to the cardboard tube to
capture any strong incidences of movement, which may produce imaging
artifacts during the study. An air puffer, supplied by a custom air-puffing system,
was place 2cm in front of the right vibrissa of the mice. An additional air puffer
was angled at the base of the tail of the animal as a control for general sensory
arousal.
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Figure 4. Schematic of Imaging Setup.
A tunable Ti-Sapphire laser provides excitation in the infrared range (800nm excitation was used
for this study). Excitation light, which passes through the long-pass (700 nm cut-off) dichroic
mirror, is focused, through the objective, to a very fine point which is rastered by scanning
mirrors. Emission light passes back through the same objective, but is reflected by the dichroic
mirror due to a higher wave frequency (shorter wavelength). Data was collected from the PMTs
by an imaging computer, which was also used to drive the air-puff system.

The imaging

computer was linked to an auxiliary computer, which collected data from an ADXL accelerometer
mounted on the restraint tube, for error correction, and physiological data from the pulse
oximeter.
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Imaging/Stimulation Procedure
At each time frame, imaging was performed in imaging sessions that did
not exceed 4 hours over the course of one or more days. Prior to fixation in the
imaging apparatus, mice were anesthetized in an enclosed container with 4%
isoflurane until a deep plane of anesthesia was reached as determined by the toe
pinch test. Once anesthetized, 0.05mL of 5.0% 2MDa FITC-dextran in PBS was
introduced using a retro-orbital injection. If a noticeable deterioration in imaging
quality attributable to declining dye concentrations was noticed during imaging
sessions, the mouse was anesthetized with a nose-cone and re-injected with
FITC.
Imaging of arteriole dilations was performed with a 20x Olympus objective
with 1.0x digital zoom, a 512x400 pixel (312 x 244µm) imaging field, and a frame
acquisition rate of 4.34 fps. For imaging with FITC-dextran, the excitation laser
was tuned to 800nm and emissions were collected with a PMT with a filter
passing green wavelengths.
Air puffers were supplied with 35 P.S.I. air and programmed to provide an
8 Hz duty cycle of 20ms open, 105ms closed, for 10 seconds. Areas of interest
were determined by locating branching arterioles that exhibited a noticeable
dilatory response to vibrissa stimulation. Four to six regions of interest were
located per animal during pre-occlusion imaging.
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To determine the dilatory properties of arterioles in each region of interest,
a randomized stimulation paradigm consisting of 20 x 2-minute trials was
performed. As shown in Figure 5A, each individual trial consisted of an initial
baseline period of 30 seconds followed by 10 seconds of stimulation.

After

stimulation, a 50 second recovery period was included to allow arteriole
conditions to recover to baseline. For each trial, the stimulation type was semirandomized between vibrissa and tail stimulation so that 10 trials of each type
occurred. Each individual trial was recorded as an individual .MPD file.
Following photothrombotic occlusion, the stimulation paradigm was carried
out again in regions that were still imageable in the acute, subacute, and chronic
time frames.
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Figure 5. Stimulation Paradigm and Example of Dilation.
(A) Stimulation trials consisted of a 30 second pre-stimulation period, a 10 second stimulation
period, and an 80 second post-stimulation period. 20 randomized trials, consisting of 10 vibrissa
stimulations and 10 tail stimulations, were carried out to assess each region of interest. An
additional 2 minute video was taken without stimulation to assess the quiescent behavior of the
arterioles. (B) Example of arterioles dilating during vibrissa stimulation with traces showing
arterioles and venules below.
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Photothrombotic Stroke
Following the completion of pre-occlusion imaging, the mice were briefly
anesthetized with 3% isoflurane in air supplied through a nosecone. Once a
deep plane of anesthesia was reached, 0.025mL of 1.25% rose Bengal dye in
PBS was injected retro-orbitally.
discontinued.

Immediately after injection, isoflurane was

To aid in localization of the stroke to the barrel cortex, a

penetrating arteriole previously observed to have a dilatory response to vibrissa
stimulation was selected for targeted occlusion.

After targeting the chosen

arteriole with the two-photon system, a 530nm green laser was introduced along
the microscope’s light path with a moveable mirror, and focused through the
objective to a point, 20µm in diameter, at the imaging plane, shown in Figure 6.
The power of the green laser at its focus was 1 mW. The targeted penetrating
arteriole was exposed to the laser for 30-45 seconds, during which the laser
induced photolytic activation of circulating rose Bengal dye, creating free
radicals, which in turn irritated the vascular wall initiating the clotting cascade.
After laser exposure, the two-photon system was used to image the
targeted arteriole again to determine if occlusion was successful. If the arteriole
failed to occlude, the vessel was targeted for green laser exposure again. Rose
Bengal dye, which has a very short half-life, was re-injected, under anesthesia, if
occlusion could not be achieved within 15 minutes.

Mice were again briefly

imaged at 30-minutes and 60-minutes to monitor for de-occlusion of the vessel.
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Figure 6. Schematic of Targeted Photothrombotic Occlusion of an Arteriole.
Intravenous Rose Bengal was activated with a green laser to produce ROS, causing vascular wall
irritation and thrombosis.

Data Processing
Prior to analysis, output .MPD files were converted to a .tiff format for
compatibility with matlab processing techniques. A custom matlab program was
designed to handle bulk analysis of dilation data. As demonstrated in Figure 7,
diameters of arterioles were determined by measuring the full-width halfmaximum of the vessels. That is, the distance, when moving across the width of
the vessel, from the first pixel that exceeds 50% of the intensity of the brightest
pixel in the same cross-section, to the last such pixel.
Using a custom matlab program, the diameters of any number of arterioles
within the imaging region could be measured by determining the average fullwidth half-maximum value for vessels within user-selected ROIs. As an output,

24

this analysis program gave a data structure containing individual diameter traces,
such as those in Figure 8, for each vessel analyzed in each video.

Figure 7. Example of Full-Width Half-Maximum Measurements of Dilating Arterioles
(A) Two-photon image of the pial network of surface vasculature, indicating two regions of
interest (ROIs) positioned over surface arterioles. (B) Shading vessels in the image, with
arterioles in red and venules in blue. (C) Full-width half-maximum (FWHM)measurements over
before, during, and after vibrissa stimulation in the ROIs indicated in A. (D) Lumen diameter of
the vessels within the ROIs over the course of a stimulation trial, as measured by FWHM.

A second custom program was utilized to compile data from these
structures into average diameter traces for each vessel.

After selecting a

particular vessel from a region and a stimulus type (vibrissa or tail), the program
incorporates Labchart output data from the ADXL accelerometer to screen out
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data traces that contain movement artifacts which may cause aberrations. An
average trace was then compiled from valid trials for the selected vessel.
Several parameters were calculated from these average diameter traces
for analysis in this study. First, the average baseline diameter was calculated by
taking the average diameter of the arteriole over at least 10 seconds during
which spontaneous dilation does not occur during the 30 seconds preceding
stimulation. The maximum dilation diameter and mean dilation diameter were
taken as the maximum and mean diameter of the arteriole during the 10 seconds
of stimulation.

The maximum dilation percentage and the mean dilation

percentage were calculated as the percent increase over the previously
calculated baseline average for the two values.
To assess the temporal coupling of stimulus to response, the latency to
dilation was calculated for each trace as the amount of time, in seconds, that
elapses from the initiation of stimulation to the time point at which the arteriole
diameter exceeds two standard deviations above the baseline average.
Calculation of these parameters was automated and incorporated as a
secondary function of the custom program.
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Figure 8. Vibrissa Stimulation Elicited Robust Dilation in Arterioles within the Vibrissa
Cortex.

Dilatory traces from a single vibrissa stimulation trial in two arterioles. Accelerometers affixed
to the restraint tube indicate no significant movement. Multiple trials are averaged using a
custom program, and the latency to dilation, mean dilation, and max dilation are calculated
from the average traces.
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Immunohistochemistry
Following the completion of the chronic imaging session, the mice were
injected with 0.1 mL of Euthasol and then trans-cardially perfused with 60mL
PBS followed by 10mL 4% paraformaldehyde in PBS.

The brain was then

extracted and bisected into hemispheres. The cerebellum and striatum were
delicately removed using forceps, and the remaining cortical hemispheres were
flattened between two microscope slides separated by 1/16” and anchored
together with two pairs of magnets placed at both ends of the slides.

The

microscope slide was then placed in a 60ml conical tube, submerging the brain
tissue in 4% paraformaldehyde (15mL were added to each conical). The conical
was then stored overnight at 4oC. After 24 hours, the 4% paraformaldehyde
solution was replaced by PBS, and the conical tube was stored at 4oC until tissue
was used for histology.
Prior to immunohistochemistry, flattened cortices of both hemispheres
were removed from the microscope slides and sliced into 50µm sections using a
vibratome.

For primary antibody staining, tissue slices were placed in vials

containing 2mL of antibody buffer (10 % (v/v) goat serum (Vector Labs), 2 % (v/v)
Triton X-100, and 0.2 % (w/v) sodium azide) with 1:750 mouse anti-neun
antibody (Millipore; MAB339), and 1:5,000 guinea pig anti-VGlut2 antibody (R&D
Systems; AF1042) The tissue was incubated in the primary antibody solution for
24 hours on a nutating mixer. This was followed by a 30-minute wash in PBS.
Next, the tissue was placed into a secondary solution consisting of antibody
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buffer and 1:1,000 red anti-guineau pig (Invitrogen; A11076) and 1:1,000 blue
anti-mouse (Invitrogen; A21049), and incubated for 2 hours. Next, another 30minute wash in PBS preceded the placement of the tissue onto microscope
slides which was then allowed to dry. Once dry, a coverslip was fixed to the slide
using Fluoromount-G.

c-Fos Immunohistochemistry
The proto-oncogene c-Fos, which is robustly expressed in neurons
following the firing of action potentials, was used as a tool to understand the
extent of neural activity following induction of CMI. As it is upregulated from 60
to 90 minutes following neuronal activity, immunolabeling of c-Fos could reveal
which neurons are responding to the vibrissa stimulation paradigm.
Immunohistochemistry was applied to label c-Fos in three mice for each
time frame in this study. All mice were implanted with chronic thin-skull windows
and habituated to fixation in the imaging apparatus as described previously.
Vibrissa stimulation was utilized to locate dilating arterioles in the barrel cortex to
target for occlusion. Three control mice were given sham occlusions, with focal
green laser exposure but no Rose Bengal injection. Photothrombotic occlusion
was induced in nine mice, three for each post-CMI time period.

Prior to

perfusion, mice were exposed to an 8hz train of 35 PSI air puffs to the
contralateral vibrissa pad for 20 minutes. Mice were sacrificed and perfused as
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previously described 75 minutes after stimulation. Mice with sham strokes were
perfused on the day of the sham stroke, while the mice with CMIs were sacrificed
at 48 hours (acute), 7 days (subacute), and 14 days (chronic).
Following perfusion, the brains were extracted and cortices of both
hemispheres were flattened between microscope slides and submerged in 4%
paraformaldehyde

as

previously

detailed.

For

immunohistochemistry

fluorescence labeling, tissue was first placed for 24 hours in a primary antibody
labeling solution consisting of 1:500 rabbit anti-c-Fos (Santa Cruz Biotech; sc52), 1:750 mouse anti-neun antibody (Millipore; MAB339), and 1:5,000 guinea
pig anti-VGlut2 antibody (R&D Systems; AF1042) in antibody buffer. After a 30
minute wash, tissue was added to the secondary antibody labeling solution which
consisted of 1:1,000 red anti-rabbit (Invitrogen; A11076), 1:1,000 green anti-gp
(Invitrogen; A31268), and 1:1,000 blue anti-mouse (Invitrogen; A21049).

For

labeling c-Fos, the color red was selected over green due to the chance that
residual FITC in the tissue could lead to inaccuracies when counting cells
containing c-Fos.
This tissue was then mounted on slides using Fluoromount-G, and images
were taken at 4x and 10x using a Leica fluorescence microscope. The locations
of barrels within the barrel cortex were established using the VGlut2 staining and
these parameters were taken into account when using a cell-counting macro in
ImageJ, ITCN (Image-Based Tool for Counting Nuclei) to determine density of cFos activation in each barrel.
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Results
Sensory-Evoked Arteriole Dilatory Response in Awake Mice
To assess the nature of evoked dilations in the healthy animal, data
gathered during the pre-occlusion imaging phase was pooled together. A plot of
the average dilatory response of arterioles and venules to the three stimulation
conditions is shown below, in Figure 9.

These traces were generated by

compiling the average responses from all vessels imaged during the preocclusion period throughout the entire study.

Vibrissa stimulation elicited a

robust dilatory response, which was followed by an extended, steady-state
dilation after the cessation of stimulation.
In contrast, tail stimulation as a control for general arousal resulted in brief
arteriole dilation, which returned to baseline before the termination of stimulation.
The specificity of vibrissa-evoked dilation suggested that arterioles sampled were
within the barrel field of the primary sensory cortex. Although previous research
has indicated venules exhibit a “bagpipe” capacitive effect following prolonged
vibrissa stimulation, we found no evidence of venular dilation in this study under
any stimulation conditions.
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Figure 9. Average Responses of Arterioles and Venules to Stimulation under Basal
Conditions.
Average diameter traces were calculated by averaging the traces for vibrissa stimulation, tail
stimulation, and no stimulation from all arterioles and venules in pre-stroke conditions. Shading
around the trace indicates standard error of the mean.

The average maximum dilatory response to vibrissa stimulation in
arterioles resulted in a 23.6 ± 5.9% increase in diameter, while the average
diameter during the course of stimulation was dilated 9.7 ± 3.4% over baseline
values.

In contrast, tail stimulation yielded an average maximum dilatory

response of 4.1 ± 1.3µm and an average mean dilation of 1.5 ± 0.6µm. As has
been found in previous studies(76), there was a negative correlation (r = -0.39, p
< 0.01) between baseline arteriole diameter and the degree to which arterioles
dilate maximally.
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Figure 10. Maximum Dilatory Responses of Individual Arterioles to Stimulation under
Basal Conditions.
There was no significant correlation between tail stimulation or no stimulation dilations and the
baseline diameter. There was a significant negative correlation between the baseline diameter
and the maximum dilation over baseline (r = -0.4422, p = 0.01)

Cerebral Microinfarcts were targeted to the Periphery of the Barrel
Cortex
Following chronic imaging, mice were perfused and the brain tissue was
labeled with IHC to determine the nature and location of CMIs generated by the
photothrombosis in this study, as shown in Figure 11D. The average radius of
the generated strokes was 192 ± 57.6 µm. As indicated in Figure 11E, VGLUT2
labeling of the barrel cortex revealed that strokes were concentrated around the
peripheral barrel cortex. The microinfarcts were strategically placed surrounding
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the core barrels of the vibrissa field such that the gradient of their effect could be
visualized over the imaging field.

Figure 11. Locations of Imaging Regions and Cerebral Microinfarcts Within the Barrel
Cortex
(A) The imaging window was situated over the left hemisphere vibrissa cortex, contralateral to
stimulation. (B) 4x 2-Photon vasculature map showing the site of occlusion and three regions of
interest. (C) 20x 2-Photon images of the regions of interest with yellow boxes indicating ROIs
used for calculating vessel diameters. (D) VGLUT2 staining of the barrel cortex showing the
location of a CMI. The location of the ROIs was transposed to this image using fiducials in the
histology. (E) Location of CMIs within the barrel cortex, with the general imaging region
indicated in blue. The CMI from D is indicated in orange.
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Changes in Dilatory Response Following Cerebral Microinfarct
To assess changes in dilatory response following CMI, the stimulus
responses from all viable vessels (those that could be located and identified in all
time periods following occlusion) were averaged to provide a mean trace for the
characteristic dilatory responses exhibited by arterioles over time.

Figure 12. Average Dilatory Response of Arterioles Before and Following Occlusion.
(A) Average dilatory response of arterioles to the three stimulus condition presented. (B) Mean
dilation over baseline was significantly attenuated in the acute phase, followed by significant
recovery in the subacute and chronic phases. (C) Zoom-in of the first few seconds of stimulation
reveals an increased latency to dilation in vessels during the acute and subacute time periods.

Following CMI, in the acute time phase there were obvious changes in the
dilatory response to all forms of stimulation. Although there was still a small
average dilatory response to vibrissa stimulation, the response is very brief and
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greatly attenuated. Also, there is no evidence of a steady state response in the
acute time phase. Further, tail stimulation produced no noticeable dilation.
When the same vessels were imaged again in the subacute time phase, a
robust average dilation was restored in the vessels with a small steady-state
response, albeit attenuated in magnitude compared to baseline. This was also
evident in the chronic time-phase, when a small response to tail stimulation also
returned. Taken together, this data suggests that there is a near-complete loss
of dilatory response in the acute time phase, which partially recovers in the
subacute time phase.
To give statistical power to the observations made concerning the average
dilatory traces, the data from this study was compiled using a second method.
The average trace across all viable trials for each vessel in each time frame was
generated using the custom program. Baseline diameter, average dilation over
baseline, maximum dilation over baseline, and latency to dilation were
determined for each trace, and this data was compiled for each time frame for
vessels from the same population of arterioles which could be visualized through
all time frames. Shown in Figure 13, mean dilation over baseline during prestroke imaging was 9.8%, which significantly dropped to 1.8% in the acute time
phase, followed by a recovery in the subacute and chronic phases during which
the mean dilation was 7.6% and 7.1% respectively. Similarly, a significant loss of
maximum dilatory capacity was also observed in the acute time phase, followed
by significant recovery in the subacute and chronic time phases, as shown in
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Figure 10.

Additionally, there was a significant increase from pre-occlusion

values in latency to dilation during the acute and subacute time periods. This
was followed by a significant recovery of latency to dilation during the chronic
time period.

Figure 13.
Periods.

Mean Latency of Dilation is Augmented in the Acute and Subacute Time

Using a two-tailed t-test, the latency to dilation was compared between time periods. As
indicated in the graph, pre-occlusion values were significantly lower (p < 0.01) than those in the
acute and subacute time periods. Likewise, the mean latency in the chronic time period was
significantly lower (p < 0.01) than in the acute and subacute time periods.

In previous studies, an inverse correlation has been noted between
maximum dilation over baseline and the baseline diameter of an arteriole (76)
When maximum dilation over baseline was plotted against the baseline diameter,
the same correlation was found in the pre-CMI time period of this study; however
the correlation is completely abolished in acute time phase. There is partial
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recovery of this trend later in the study, as the correlation re-emerged in the
subacute and chronic time phases, albeit with a wider spread of responses.

Figure 14. Loss of Dilatory Response in the Acute Time Phase effects both Small and
Large Vessels.
(A) In the acute time phase, there was a positive correlation between baseline vessel diameter
and the preserved dilatory response, however, the dilatory function of both small and large
vessels was significantly attenuated in the acute time phase (B).

To determine whether the magnitude of the mean dilatory response might
exhibit the same negative correlation to baseline diameter, the mean change in
dilation from baseline was plotted against the baseline lumen diameter. In the
pre-occlusion phase, there was a negative trend, but no significant correlation in
contrast to what was observed with maximum dilation diameters, as shown in
Figure 14A.

Interestingly, a strong, positive correlation emerged in the acute

phase, indicating that larger vessels may be capable of preserving greater
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dilatory capacity. Although this trend was not preserved in the subacute and
chronic phases, it points to the interesting conclusion that the effects of CMI may
be more deleterious for neurovascular coupling in smaller vessels. In the acute
phase there were a number of vessels that responded to vibrissa stimulation with
a net negative dilation, potentially due to vascular steal.
To probe whether small vessels may have a different outcome than large
vessels following CMI, the vessels were separated into two sub-populations,
those less than and those greater than 25µm in baseline diameter. Indicated in
Figure 14B, there was a significant loss in mean dilatory response in both sets of
vessels during the acute time-phase followed by significant recovery in the
subacute and chronic phases, indicating that the dilatory response for both sets
of arterioles was similarly impacted following CMI.

Correlations between Changes in Dilatory Response and Position
Relative to CMI
Dilatory responses were measured in vessels that covered a wide range
of distances from the sites of targeted photothrombotic occlusions. As a strong
loss of dilatory response was observed in the composite data from all vessels,
varied locations of sampled vessels could elucidate whether this loss of dilatory
response was a broad effect, or whether the bulk of changes in dilatory capacity
took place in the immediate vicinity of the CMI.

Shown in Figure 15A, the
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dilatory responses for vessels, normalized to the pre-occlusion responses from
the same vessels, were plotted against the distance from the putative stroke
border as determined by 4x two-photon maps and VGlut2 IHC.

Figure 15. Loss of dilatory response extended far beyond the CMI border during the acute
time phase.
(A) While vessels far outside of the CMI border were impacted in the acute time phase, there
was a correlation between distance from the border and retained dilatory capacity. This trend
was preserved through the subacute phase, indicating that distal vessels were impacted to a
lesser extent and recovered quicker. (B) While both proximal and distal vessels saw significant
decreases in dilatory capacity, there was significant recovery in distal vessels during the acute
phase, while proximal vessels did not significantly recover until the chronic phase. (C) The
region of deficit extended far beyond the stroke border in the acute time phase.
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There was a significant positive correlation between the distance from the
CMI border and the preserved dilatory capacity of arterioles during the acute and
subacute time periods, indicating that vessels further from the border were more
likely to preserve dilatory responses in those particular time frames.
To analyze whether distal and proximal vessels were differentially affected
by CMI, the vessels analyzed in this study were broken into two groups,
proximal, which were vessels within 100µm of the CMI border, and distal
arterioles, located greater than 100µm away.

The cut-off distance for this

analysis was situated just outside of the overt CMI border, to account for a
narrow ring of gliotic, non-normal tissue surrounding the CMI core. Arterioles
within this cut-off included those in the immediate peri-infarct as well as the few
viable arterioles within the CMI core. Both data sets saw a significant decrease
in dilatory response; however, while distal arterioles exhibited a significant
recovery beginning in the subacute time phase, proximal arterioles did not show
significant recovery from acute dilatory responses until the chronic time phase.
This indicates that both proximal and distal arterioles are similarly impacted by
CMI in the acute time phase, but distal arterioles exhibit a quicker, more robust
recovery in the subacute and chronic time phases. Nonetheless, this indicates
that the loss of dilatory response extends far beyond the borders of the CMI
during the early days following occlusion.
Change in latency, which was calculated as the change in time, in
seconds, from latency to dilation for a given vessel during pre-occlusion imaging,
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was also plotted against distance from the CMI border for all three post-stroke
time phases in Figure 16A.

Figure 16. Both proximal and distal vessels experienced increase in latency to dilation
following stroke.
(A) There was a negative correlation between distance from CMI border and increase in latency
to dilation during the acute and subacute time periods, indicating that vessels proximal to the
stroke were slower to dilate. (B) Both proximal and distal vessels exhibited increased latency to
dilation in the acute and subacute time periods.
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With this data, a strong negative correlation between distance from stroke
border and change in latency was found in the acute and subacute time phases,
indicating that vessels closer to the core of the CMI exhibited a greater latency to
dilation.

However, when latency data was broken into proximal and distal

groups, both sets of data exhibited significant augmentation in latency to dilation
in the acute and subacute time periods, followed by significant recovery in the
chronic time period, indicating that CMIs are capable of broadly disrupting
temporal neurovascular coupling.

Genesis of a Deficit – Neurovascular Coupling in Hyper-Acute Stage
of Cerebral Microinfarction
To gain a better understanding of the means by which neurovascular
deficits evolve from the initial occlusion to the broad effects measured at the
acute phase, a separate, small cohort of mice were utilized to model the
neurovascular hyper-acute (20 min. to 3 hrs. post-occlusion) time period
following targeted photothrombotic occlusion of penetrating arterioles.

43

Figure 17: Neurovascular Coupling is Disrupted Proximal to Stroke in the Hyperacute
phase.
A. Mean dilation over baseline rapidly diminished in repeatedly measured arterioles in the first
three hours following microvascular occlusion. B. This loss of dilatory capacity is reflected in the
average traces for arteriole dilation. C. Following targeted occlusion, there was a significant
correlation between proximity to the occluded vessel and loss of dilatory function. This
correlation became more pronounced over the course of hyperacute imaging.

As early as 20 minutes following the occlusion, dilatory deficits were found
in many arterioles within 150µm of the occluded vessel. One hour following
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occlusion, the dilatory deficit extends to 300µm from the occluded penetrating
arteriole.

Isoflurane and c-Fos – Tools to Probe the Mechanisms of the Loss of
Dilatory Response
The widespread loss of dilatory response found in the acute time phase
indicates that there is at least a temporary breakdown of neurovascular coupling.
This could be attributable to a number of factors, as there are a number of
components that drive neurovascular coupling in the neurovascular unit. In this
study, we chose to investigate the two candidates that are seemingly the most
likely to be the source of this deficiency and the two principal components of the
neurovascular unit, the sensory neurons which respond to stimuli, eventually
driving vascular activity, and the vascular wall itself. To probe for deficits in
neuronal activity, c-Fos, a proto-oncogene upregulated following extensive
neuronal activity, was utilized to quantify neurons responding to the stimulus
paradigm used in this study (77). Changes in vascular wall compliance were
investigated using Isoflurane, a volatile anesthetic common in veterinary
medicine, which is also a potent vasodilator (78).
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Figure 18. Isoflurane is capable of inducing far larger dilations than vibrissa stimulation.
Full-Width Half-Maximum measurements across the same arteriole reveal that isoflurane
exposure induces dilations that exceed the dilatory response seen during vibrissa stimulation.

Isoflurane was administered to mice following imaging sessions at a
concentration of 3.0% in air for 3 minutes. During this brief period of exposure, a
movie was collected across all imaging regions to capture the extent of dilation
during isoflurane exposure. The average dilation over baseline during isoflurane
exposure was much greater than the maximum dilations achievable with the
vibrissa stimulation paradigm during all time periods, indicating the vascular wall
was capable of dilating well beyond the attenuated dilations seen following CMI.
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Although this indicates that vascular wall stiffening cannot be the sole source of
the loss of dilatory response, a significant decrease in isoflurane-induced
dilations over baseline was evident in the acute phase, pointing toward vascular
wall compliance issues as a potential contributing factor.

Figure 19. Dilations induced by isoflurane exposure were significantly attenuated in the
acute phase, but still greatly exceeded the dilatory response to vibrissa stimulation.
Isoflurane was capable of dilating arterioles well beyond the maximum dilatory responses to
stimulation during all time periods in this study. While there is a significant decrease in isoflurane
induced dilation diameters in the acute time phase, these results indicate that it is unlikely that
changes in vascular wall compliance are the only contributing factor to the loss of sensoryinduced dilatory response seen in the acute phase.
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Figure 20. Immunofluorescence staining of c-Fos reveals robust neuronal activation in the
barrel cortex contralateral to vibrissa stimulation in a sham animal.

In sham CMI animals, c-Fos was homogenously expressed at low levels
throughout cortex ipsilateral to vibrissa stimulation, with a slight elevation in the
primary vibrissa cortex. In the contralateral cortex, however, c-Fos was robustly
expressed in the barrel cortex.
When mice were perfused during the acute time period following
occlusion, the expression of c-Fos was reduced in a broad region of cortex
extending up to 1mm outside of the stroke core, as shown in Figures 21 & 22.
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Figure 21. c-Fos activation in the barrel cortex contralateral to vibrissa stimulation is
diminished in the acute phase following CMI.
Following CMI, the number of c-Fos+ cells in the barrel cortex is greatly reduced in the acute
phase. As the CMI progresses into the subacute and chronic time periods, more cells were cFos+ in the peri-infarct cortex following prolonged vibrissa stimulation.

In mice that were sacrificed during the subacute time period, c-Fos levels
began to recover from the acute deficit, with the region of inactive neurons
extending only 200-400µm outside of the putative stroke border, shown in Figure
22. By the chronic time period, the expression of c-Fos had recovered even
further, as many neurons within the peri-infarct strongly expressing the protooncogene following prolonged sensory stimulation. This data points toward a
chronic, robust recovery of neurovascular coupling in the peri-infarct cortex.
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Figure 22. Expression of c-Fos is attenuated proximal to the CMI in the acute and
subacute phases.
(A&B) A 100µm x 500µm ROI was placed to sample cfos activity as a function of

distance from CMI. Another ROI was placed across the barrel cortex of a sham animal,
covering the same barrels, to provide a control for basal stimulation expression. (C) cFos expression was reduced proximal to the CMI when compared to the control across
the same barrel regions.
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Discussion
The impact of microvascular lesions, as often observed in the aging
human brain, on neurovascular coupling is currently not well understood. To
probe this issue, we have utilized a mouse model of microinfarct pathology based
on selective occlusion of individual penetrating arterioles and venules in the
mouse barrel cortex. Neurovascular coupling was first assessed longitudinally by
two-photon imaging of arterioles during vibrissa stimulation using air puffs during
four time-periods: pre-occlusion, acute (2-3 days post occlusion), subacute (7-9
days post occlusion), and chronic (14-21 days post occlusion).

The mean

dilation from baseline diameter was significantly attenuated during the initial
acute imaging period.

Despite being relatively small in size (≈400µm in

diameter), CMIs generated in this experiment were capable of eliciting a
widespread and persistent dilatory deficit in the surrounding cortex, with deficits
occurring in arterioles up to 1mm outside of the putative stroke boundary.
The widespread impact of these targeted microvessel occlusions is likely
attributable to the process of diaschisis, a term coined by van Monakow in 1914
to describe neurophysiological changes that occur distant to a focal brain
lesion(79).

These neurophysiological phenomena can be classified into two

categories: Focal diaschisis, and connectional diaschisis. Focal diaschisis might
occur during cortical strokes as the result of white matter tract degeneration in
underlying subcortical tissue. While the microinfarcts induced in this study are
unlikely to cause any form of extensive subcortical damage, it should be noted
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that diffusion MRI studies in clinical stroke patients revealed that subcortical
disconnection extends well beyond the locus of tissue necrosis, affecting major
white matter pathways (80).
In the case of the targeted photothrombotic occlusions generated in this
stroke model, it is more likely that expansive dilatory deficit is an example of
connectional diaschisis, which encompasses changes in structural and functional
connectivity between the lesion area and distal brain regions. While the barrel
cortex is functionally segregated into barrels directly associated with individual
vibrissa, there is still a high level of interconnectivity between barrels. Regular
spiking pyramidal cells in layer 5 are tuned to respond to activity in surrounding
barrels(81), while neurons in layer 2/3 also exhibit a high level of connectivity to
surround barrels (82).

Disruption of this inter-barrel connectivity could

conceivably be contributing to the loss of neurovascular coupling in the days
following CMI.

A possible mechanism of this alteration in barrel-to-barrel

connectivity may be remodeling the axon initial segment (AIS). AIS length is
acutely decreased in the peri-infarct cortex, particularly affecting neurons with
distal axons projecting in the infarcted area(42). The decrease in length occurs
at the distal AIS, as axons essentially retract from the infarcted tissue, likely
driving cortical reorganization.

One limitation of the photothrombotic stroke

model utilized is the potential for non-focal activation of intravenous rose-Bengal
dye during targeted green laser illumination. Diffuse light below and adjacent to
the site of occlusion could be causing low-level activation of rose Bengal dye,
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generating free-radicals which could contribute to the ischemic damage observed
well outside the infarcted tissue both in this study and in other studies utilizing
photothrombotic stroke models.

In addition to connectional diaschisis,

widespread BBB breakdown observed in cortex during the subacute and chronic
time periods both contralateral and ipsilateral to focal stroke may contribute to
the broad effects of diaschisis(83, 84).
At the subacute imaging time frame, vessels exhibited significant, albeit
incomplete, recovery from the dilatory deficit of the acute phase.

Proximal

vessels (those within 100µm of the putative stroke border) did not exhibit
significant recovery of dilatory capacity during this time frame, indicating that
deficit is likely prolonged in arterioles closer to the site of infarction, which is also
suggested by a strong positive correlation between the distance from the stroke
and the relative level of preserved dilatory capacity in the subacute phase.
Previous research has provided evidence of broad hyperexcitability during the
subacute phase in brain regions both ipsilateral and contralateral to ischemic
stroke(85), which may drive the functional recovery of mean dilatory capacity in
arterioles distal to the microinfarct. Electrophysiological paired-pulse studies in
rat brain slices have shown extensive hyperexcitability in the contralateral
hemisphere, as well as ipsilaterally as close as 1mm away from infarcted tissue.
Hyperexcitability has also been found seven days post occlusion with
optogenetic mapping utilizing ChR2-evoked voltage sensitive dye responses(86).
It should also be noted that, in the same study, regions distal to the infarct
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exhibited upscaling of the evoked response, while connectomics analysis
indicated that neurons closely connected to the peri-infarct were damaged
whereas areas with little peri-infarct connection escaped damage, provide
rationale to the often heterogeneous recovery observed in the tissue surrounding
a stroke.

While overt hyperexcitability was not detected in the form of an

enhanced dilatory response, distal arterioles were more likely to preserve dilatory
function in the acute phase, and exhibited significantly greater recovery in the
subacute phase when compared to proximal arterioles.

At the chronic time

period, arterioles proximal to the CMI exhibited significant, yet incomplete,
recovery of dilatory capacity from the acute deficit, which in effect abolished the
correlation between dilatory function and proximity of arterioles to the infarct.
This may indicate the recovery of neurovascular coupling in the spared cortex by
way of functional reorganization and synaptogenesis.
The rapid, local deficit observed in the hyperacute experiment could be
attributed to a number of mechanisms initiating in the early onset of stroke. In a
model of focal ischemia, brain regions that exhibited severe ischemia (<10% of
original CBF maintained) underwent rapid loss of spine and dendritic structure in
as little as 10 minutes(87).

The ensuing rapid spread of neurovascular

decoupling is likely driven by secondary damage and proliferation of the stroke,
initiated with the rapid release of ROS and pro-inflammatory mediators from
apoptotic cells in the ischemic tissue(88). These mediators activate microglia,
which

are

endogenously

held

in

check

by

tonic

inhibitory

signaling,
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morphologically altering the cells from a ramified to an amoeboid morphology
and releasing inflammatory cytokines and chemokines which can exacerbate or
conversely help repair ischemic injury(62). Specifically, the increased levels of
cytokines and chemokines facilitate adhesion and trans-endothelial migration of
circulation leukocytes(89).

These infiltrating leukocytes may release pro-

inflammatory mediators, including cytokines, chemokines, and ROS which
contribute to the evolution of tissue damage(90) and drive the infiltration of
various inflammatory cells, including neutrophils, t-cell subtypes, and additional
monocytes and macrophages(91). In addition to the biochemical impact of rolling
leukocytes within the microvasculature, leukocyte adhesion might mechanically
limit vascular perfusion of the infarcted tissue, as frequent flow stagnation of
deep cortical capillaries has been observed due to leukocyte plugging in a mouse
model of hypoperfusion(92).
In addition to the deficits seen in dilatory capacity, targeted CMIs also
appeared to impact neurovascular coupling by significantly prolonging the latency
to dilation during vibrissa stimulation in both the acute and subacute time
periods.

There was also a significant correlation between the proximity of

arterioles to the CMI and the increase in latency to dilation, indicating that, in
addition to causing broad dilatory deficits, CMIs have a stronger deleterious
effect on temporal neurovascular coupling in arterioles proximal to the infarct.
This adjustment in temporal neurovascular coupling may reflect the ongoing
process of axonal rewiring during recovery from ischemic stroke, which is
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facilitated by inhibition of growth inhibitory molecules in the peri-infarct for up to 1
month following injury.

Axonal rewiring occurs in three phases following

stroke(93). In the early phase, from days 1 to 3, rhythmic and synchronized
neuronal discharges, similar to those in the developing brain, induce axonal
sprouting. Starting at day 3, genes for growth cone lipid raft proteins GAP43,
Cap23, and MARCKS as well as the transcription factor c-Jun are induced and
persist through the duration of the sprouting process(94). The increased latency
to sensory induced dilation present in the acute phase, and persisting to the
subacute phase, could be attributed to shifting functional connectivity. Axons
projecting into the region of infarction are pruned, while immature spines forming
on surviving neurons in the peri-infarct have yet to establish strong functional
connections, leaving a relatively disjointed system that is slow to respond to
stimulus. In the middle phase of the sprouting response, cell adhesion molecules
help guide the sprouting response and form new connections. The final stage of
the sprouting process involves cytoskeletal reorganization genes SCG10 and
SCLIP, which aide in the maturation of the sprouting process.

This final

maintenance phase initiates 7-14 days post ischemia, and results in the
formation of an anatomically distinct pattern of connections(93).
To further investigate our findings, we utilized two assessments to
ascertain whether the source of the deficits might be attributable to alteration in
vascular mechanics, or in neuronal signaling. Vascular alterations occurring in
the early stages following stroke include the adoption of tortuous morphologies in
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penetrating vessels(95), leukocyte rolling and adhesion(92), and swollen and
vacuolated endothelial cells(83), all of which can impact CBF. Acute isoflurane
administration was performed before occlusion, and in the acute, subacute, and
chronic phase to investigate whether endothelial cell alterations might
mechanically inhibit vascular dilation.

Isoflurane induced dilations were

significantly attenuated in the acute time phase, coinciding with the most
significant dilatory deficits, however, there was recovery to baseline in the
subacute and chronic phases.

Isoflurane induces vasodilation of cerebral

vessels at least partially through the activation of ATP-sensitive K+ channels on
the endothelial cells(78), a pathway also present in the neurovascular signaling
unit(15). A reduction of these receptors, or a deficit in endothelial cell reactivity
to them, may contribute to the dilatory deficit observed in the peri-infarct following
cerebral microinfarction.

In addition, it has been found that vascular smooth

muscle F-actin is reduced following 1 hour of middle cerebral artery occlusion,
which could be promoting vascular damage and limiting vascular wall
compliance(96).
Due to the complexity of neurovascular coupling, we used the protooncogene c-Fos, which is upregulated following strong neuronal activation, as a
simple probe to determine whether viable neurons in the peri-infarct were
capable of responding to sensory stimuli. c-Fos expression was greatly reduced
in the acute mouse, with severe deficits extending up to 1mm from the ischemic
stroke core.

While previous studies have indicated that endogenous c-Fos is
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briefly upregulated following focal ischemia(97, 98), with peak values occurring at
60 minutes post occlusion, the time point used for this study does not coincide
with these findings, and no upregulation of c-Fos activity is indicated in our
results.

Instead, widespread deficits that present acutely persist into the

subacute time phase, indicating poor neuronal connectivity during a period of
synaptogenesis and neuronal rewiring.
The results of this study help to shed light on the microvascular
environment and on alterations in neurovascular coupling at the level of
individual vessels, and provide a microvascular correlate to previous BOLD fMRI
findings. The data in this study reveals that CMIs, though small in size, can
impact neurovascular coupling in a broad region of cortex, elucidating a
mechanism by which microinfarcts may cause cognitive impairment. As CMIs
have previously been associated with dementia in the elderly, these findings
indicate that the neurovascular unit, in addition to being a crucial component in
stroke therapy, may be a crucial target for therapeutic approaches to dementia in
the future.
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